Administration of a GnRH agonist during the luteal phase frozen–thawed embryo transfer cycles: a meta-analysis

References

• Isik AZ, Caglar GS, Sozen E, et al. Single- dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study. Reprod Biomed Online. 2009;19:472–477.
   PubMed Web of Science ®Google Scholar
• Razieh DF, Maryam AR, Nasim T. Beneficial effect of luteal-phase gonadotropin-releasing hormone agonist administration on implantation rate after intracytoplasmic sperm injection. Taiwan J Obstet Gynecol. 2009;48:245–248.
   PubMed Web of Science ®Google Scholar
• Geber S, Sampaio M. Effect of duration of the GnRH agonists in the luteal phase in the outcome of assisted reproduction cycles. Gynecol Endocrinol. 2013;29:608–610.
   PubMed Web of Science ®Google Scholar
• Kung HF, Chen MJ, Guua HF, et al. Luteal phase support with decapeptyl improves pregnancy outcomes in intracytoplasmic sperm injection with higher basal follicle-stimulating hormone or lower mature oocytes. J Chin Med Assoc. 2014;77:524–530.
   PubMed Web of Science ®Google Scholar
• Aboulghar MA, Marie H, Amin YM, et al. Mansour. GnRH agonist plus vaginal progesterone for luteal phase support in ICSI cycles: a randomized study. Reprod Biomed Online. 2015;30:52–56.
   PubMed Web of Science ®Google Scholar
• Inamdar DB, Majumdar A. Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome. J Hum Reprod Sci. 2012;5:279–284.
   PubMedGoogle Scholar
• Yıldız GA, Şükür YE, Ateş C, et al. The addition of gonadotrophin releasing hormone agonist to routine luteal phase support in intracytoplasmic sperm injection and embryo transfer cycles: a randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2014;182:66–70.
   PubMed Web of Science ®Google Scholar
• Pirard C, Donnez J, Loumaye E. GnRH agonist as luteal phase sup-port in assisted reproduction technique cycles: results of a pilot study. Hum Reprod. 2006;21:1894–1900.
   PubMed Web of Science ®Google Scholar
• Tesarik J, Hazout A, Mendoza-Tesarik R, et al. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist-and antagonist-treated ovarian stimulation cycles. Hum Reprod. 2006;21:2572–2579.
   PubMed Web of Science ®Google Scholar
• Raga F, Casañ EM, Kruessel JS, et al. Quantitative gonadotropin-releasing hormone gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle. Biol Reprod. 1998;59:661–669.
   PubMed Web of Science ®Google Scholar
• Le Lannou D, Griveau JF, Laurent MC, et al. Contribution of embryo cryopreservation to elective single embryo transfer in IVF-ICSI. Reprod Biomed Online. 2006;13:368–375.
   PubMed Web of Science ®Google Scholar
• Shapiro BS, Daneshmand ST, Garner FC, et al. Clinical rationale for cryopreservation of entire embryo cohorts in lieu of fresh transfer. Fertil Steril. 2014;102:3–9.
   PubMed Web of Science ®Google Scholar
• Shapiro BS, Daneshmand ST, Garner FC, et al. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen–thawed embryo transfer in normal responders. Fertil Steril. 2011;96:344–348.
   PubMed Web of Science ®Google Scholar
• Park CW, Choi MH, Yang KM, et al. Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment. Clin Exp Reprod Med. 2016;43:169–173.
   PubMedGoogle Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
   PubMed Web of Science ®Google Scholar
• Gogce M, Benchaib M, Hadj S, et al. Administering GnRH agonists in the luteal phase of artificial cycle frozen–thawed embryo transfers. A prospective randomized study. Gyné Cologie Obsté Trique Fertilite. 2015;43:728–734.
   PubMedGoogle Scholar
• Robab D, Maryam Farid M, Sepideh M, et al. Effects of single dose GnRH agonist as luteal support on pregnancy outcome in frozen–thawed embryo transfer cycles: an RCT. Iran J Reprod Med. 2015;13:483–488.
   PubMedGoogle Scholar
• Jigal H, Daniel L, Noa F, et al. Modifying the luteal phase support in natural cycle frozen–thawed embryo transfer improves cycle outcome. Gynecol. Endocrinol. 2015;31:891–893.
   PubMed Web of Science ®Google Scholar
• Seikkula J, Anttila L, Polo-Kantola P, et al. Effect of mid-luteal phase GnRH agonist on frozen–thawed embryo transfers during natural menstrual cycles: a randomised clinical pilot study. Gynecol Endocrinol. 2016;32:961–964.
   PubMed Web of Science ®Google Scholar
• Orvieto R, Feldman N, Lantsberg D, et al. Natural cycle frozen–thawed embryo transfer-can we improve cycle outcome? J Assist Reprod Genet. 2016;33:611–615.
   PubMed Web of Science ®Google Scholar
• Zarei A, Sohail P, Parsanezhad ME, et al. Comparison of four protocols for luteal phase support in frozen–thawed embryo transfer cycles: a randomized clinical trial. Arch Gynecol Obstet. 2017;295:239–246.
   PubMed Web of Science ®Google Scholar
• Orvieto R, Brengauz M, Feldman B. A novel approach to normal responder patient with repeated implantation failures-a case report. Gynecol Endocrinol. 2015;31:435–437.
   PubMed Web of Science ®Google Scholar
• van der Linden M, Buckingham K, Farquhar C, et al. Luteal phase support in assisted reproduction cycles. Human Reproduction Update. 2012;18:473.
   Google Scholar
• Liu X-R, Mu H-Q, Shi Q, et al. The optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis. Reprod Biol Endocrinol. 2012;10:107.
   PubMed Web of Science ®Google Scholar
• Simsek E, Bulgan Kilicdag E, Caglar Aytac P, et al. Addition of gonadotropin releasing hormone agonist for luteal phase support in in-vitro fertilization: an analysis of 2739 cycles. J Turkish German Gynecol Assoc. 2015;16:96–101.
   PubMed Web of Science ®Google Scholar
• Casañ EM, Raga F, Bonilla-Musoles F, et al. Human oviductal gonadotropin-releasing hormone: possible implications in fertilization, early embryonic development, and implantation. J Clin Endocrinol Metabol. 2000;85:1377–1381.
   PubMed Web of Science ®Google Scholar
• Nam DH, Lee SH, Kim HS, et al. Theroleofgonadotropin-releasing hormone (GnRH) and its receptor in development of porcine preimplantation embryos derived from in vitro fertilization. Theriogenology. 2005;63:190–201.
   PubMed Web of Science ®Google Scholar
• Islami D, Chardonnens D, Campana A, et al. Comparison of the effects of GnRH-I and GnRH-II on HCG synthesis and secretion by first trimester trophoblast. Mol Human Reprod. 2001;7:3–9.
   PubMed Web of Science ®Google Scholar
• Tesarik J, Hazout A, Mendoza C. Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation. Hum Reprod. 2004;19:1176–1180.
   PubMed Web of Science ®Google Scholar